A case of acute exacerbation of idiopathic pulmonary fibrosis after proton beam therapy for non-small cell lung cancer

Japanese Journal of Clinical Oncology

Volumn 42, Issue 10, 2012, Pages 965-969

  Nagano, Tatsuya ^a   Kotani, Yoshikazu ^a   Fujii, Osamu ^b   Demizu, Yusuke ^b   Niwa, Yasue ^b   Ohno, Yoshiharu ^a   Nishio, Wataru ^a   Itoh, Tomoo ^a   Murakami, Masao ^b   Nishimura, Yoshihiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HYOGO ION BEAM MEDICAL CENTER   (Japan)

Author keywords

Acute exacerbation; Idiopathic pulmonary fibrosis; Non small cell lung cancer; Proton beam therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BICARBONATE; C REACTIVE PROTEIN; CARBOHYDRATE ANTIGEN; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; PREDNISOLONE;

AGED; AMBIENT AIR; ARTICLE; BASOPHIL; BICARBONATE BLOOD LEVEL; BRONCHIECTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE EXACERBATION; EOSINOPHIL; FIBROSING ALVEOLITIS; FOLLOW UP; HUMAN; HYPOXIA; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG VOLUME; LYMPHOCYTE; MALE; MONOCYTE; MULTIMODALITY CANCER THERAPY; NEUTROPHIL; PROTEIN BLOOD LEVEL; PROTON THERAPY; RADIATION DOSE; STEROID THERAPY;

ACUTE DISEASE; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG NEOPLASMS; MALE; PROGNOSIS; PROTON THERAPY;

EID: 84866769968     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hys115     Document Type: Article

References (21)

1. Park J, Kim DS, Shim TS, et al. Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 2001;17:1216-9.
2. Simon-Blancal V, Freynet O, Nunes H, et al. Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors. Respiration 2012;83:28-35.
3. Kim DS, Park JH, Park BK, Lee JS, Nicholson AG, Colby T. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 2006;27:143-50.
4. Lee CH, Tait D, Nahum AE, Webb S. Comparison of proton therapy and conformal X-ray therapy in non-small cell lung cancer (NSCLC). Br J Radiol 1999;72:1078-84.
5. Suit H, Goldberg S, Niemierko A, et al. Proton beams to replace photon beams in radical dose treatments. Acta Oncol 2003;42:800-8.
6. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427-31.
7. Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007;2:S94-100.
8. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24:4833-9.
9. Okada T, Kamada T, Tsuji H, et al. Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS). J Radiat Res (Tokyo) 2010;51:355-64.
10. Sobin LH, Wittekind C, editors. TNM Classification of Malignant Tumors. Hoboken, NJ: Wiley and Sons 2002;97-107.
11. Chiyo M, Sekine Y, Iwata T, et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg 2003;126:1141-6.
12. Iwata H, Murakami M, Demizu Y, et al. High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer. Cancer 2010;116:2476-85.
13. Kanzaki M, Kikkawa T, Maeda H, et al. Acute exacerbation of idiopathic interstitial pneumonias after surgical resection of lung cancer. Interact Cardiovasc Thorac Surg 2011;13:16-20.
14. Kenmotsu H, Naito T, Kimura M, et al. The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer. J Thorac Oncol 2011;6:1242-6.
15. Koizumi K, Hirata T, Hirai K, et al. Surgical treatment of lung cancer combined with interstitial pneumonia: the effect of surgical approach on postoperative acute exacerbation. Ann Thorac Cardiovasc Surg 2004;10:340-6.
16. Minegishi Y, Takenaka K, Mizutani H, et al. Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy. Intern Med 2009;48:665-72.
17. Miyamoto T, Yamamoto N, Nishimura H, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 2003;66:127-40.
18. Okamoto T, Gotoh M, Masuya D, et al. Clinical analysis of interstitial pneumonia after surgery for lung cancer. Jpn J Thorac Cardiovasc Surg 2004;52:323-9.
19. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
20. Choi YW, Munden RF, Erasmus JJ, et al. Effects of radiation therapy on the lung: radiologic appearances and differential diagnosis. Radiographics 2004;24:985-97.
21. Aubry MC, Myers JL, Douglas WW, et al. Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis. Mayo Clin Proc 2002;77:763-70.